CDMO: Avid Bioservices, Inc EV/EBITDA Multiple

Avid Bioservices, Inc. (CDMO) specializes in the production of complex biologics, utilizing a distributed synthesis network to protect supply chains and sustain profits. However, reliance on a narrow client base and the costs of equipment upgrades are putting pressure on margins. The current EV/EBITDA ratio stands at , which is clearly illustrated by this daily price chart.

CDMO Avid Bioservices Inc: Total Company Value to Operating Income Before Depreciation Ratio in the range 07/04/2022 - 11/14/2026

Analytical breakdowns for Avid Bioservices, Inc.

- stock price and consensus target price:

Stock Quotes Avid Bioservices, Inc|CDMO - Analyst Forecast Prices

- market capitalization information:

Market Capitalization Avid Bioservices Inc|CDMO - Total Enterprise Value

- issuer book value statistics:

Net Assets per Single Share Avid Bioservices|CDMO - Book Valuation of Business|Market Cap to Net Assets Ratio avidbio.com|CDMO - Aggregate Business Assets

- debt and liquidity data:

- business earnings and investment ratios data:

CDMO - Company Profit|Future Profit Avid Bioservices, Inc.|CDMO - Company Value to Net Income|Forward P/E Multiple Avid Bioservices, Inc.|CDMO - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Avid Bioservices Inc|CDMO - Operating income before deduction of amortization|Earnings per share for the last twelve months Avid Bioservices|CDMO - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months avidbio.com|CDMO - Expected net earnings per share growth this year|Earnings growth forecast for next year Avid Bioservices, Inc.

- sales volume and revenue indicators:

CDMO - Company Total Revenue|Company Projected Revenue Avid Bioservices, Inc|CDMO - Market Capitalization-to-Revenue Ratio|Forward Price-to-Revenue Multiple Avid Bioservices Inc

Fundamental company analysis:Avid Bioservices, Inc (CDMO)

Investors use this ratio to determine the fair value of a capital-intensive business relative to its ability to generate cash flow. The metric compares enterprise value (EV) to EBITDA, neutralizing the impact of debt loads and tax regimes. For Avid Bioservices, Inc. (CDMO), with its lengthy FDA validation cycles and long-term B2B contracts, changes in the EV/EBITDA ratio serve as an indicator of market confidence in the sustainability of its production capacities.

Who Avid Bioservices, Inc. competes with

IQVIA Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio LH (LabCorp)|Medpace Holdings, Inc. - EV/EBITDA Multiple|Company Value to EBITDA ICON Public Limited Company|Charles River (CRL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|EVO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio FTRE|LFCR (Lifecore) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OmniAb, Inc. (OABI)|Total Company Value to Operating Income Before Depreciation Ratio inotivco.com|EV/EBITDA Multiple CTLT (Catalent)|EV/EBITDA Multiple Scorpius Holdings Inc. SCPX